Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt repayments
Ratios

Fortress Biotech (FBIO) Accumulated Depreciation & Amortization: 2013-2025

Historic Accumulated Depreciation & Amortization for Fortress Biotech (FBIO) over the last 13 years, with Sep 2025 value amounting to $5.1 million.

  • Fortress Biotech's Accumulated Depreciation & Amortization fell 57.78% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.0 million, marking a year-over-year decrease of 35.64%. This contributed to the annual value of $12.1 million for FY2024, which is 36.17% up from last year.
  • Per Fortress Biotech's latest filing, its Accumulated Depreciation & Amortization stood at $5.1 million for Q3 2025, which was up 1.88% from $5.0 million recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's Accumulated Depreciation & Amortization ranged from a high of $13.3 million in Q1 2023 and a low of $4.9 million during Q1 2025.
  • In the last 3 years, Fortress Biotech's Accumulated Depreciation & Amortization had a median value of $8.9 million in 2023 and averaged $9.0 million.
  • As far as peak fluctuations go, Fortress Biotech's Accumulated Depreciation & Amortization skyrocketed by 47.00% in 2021, and later crashed by 58.05% in 2025.
  • Quarterly analysis of 5 years shows Fortress Biotech's Accumulated Depreciation & Amortization stood at $9.4 million in 2021, then surged by 32.49% to $12.4 million in 2022, then dropped by 28.56% to $8.9 million in 2023, then spiked by 36.17% to $12.1 million in 2024, then crashed by 57.78% to $5.1 million in 2025.
  • Its Accumulated Depreciation & Amortization stands at $5.1 million for Q3 2025, versus $5.0 million for Q2 2025 and $4.9 million for Q1 2025.